These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The effect of mechanical properties of iron oxide nanoparticle-loaded functional nano-carrier on tumor targeting and imaging. Choi WI; Kim JY; Heo SU; Jeong YY; Kim YH; Tae G J Control Release; 2012 Sep; 162(2):267-75. PubMed ID: 22824783 [TBL] [Abstract][Full Text] [Related]
4. Targeting tumor cells using magnetic nanoparticles - a feasibility study in animal models. Goren K; Neelam N; Yuval JB; Weiss DJ; Kunicher N; Margel S; Mintz Y Minim Invasive Ther Allied Technol; 2022 Oct; 31(7):1086-1095. PubMed ID: 36148547 [TBL] [Abstract][Full Text] [Related]
5. Biodistribution and histological analysis of iron oxide-dextran nanoparticles in wistar rats. Hannon G; Bogdanska A; Keogh A; Finn SP; Gobbo OL; Prina-Mello A Nanotoxicology; 2023 Dec; 17(8-9):562-580. PubMed ID: 37982374 [TBL] [Abstract][Full Text] [Related]
6. Mitoxantrone-iron oxide biodistribution in blood, tumor, spleen, and liver--magnetic nanoparticles in cancer treatment. Krukemeyer MG; Krenn V; Jakobs M; Wagner W J Surg Res; 2012 Jun; 175(1):35-43. PubMed ID: 21470623 [TBL] [Abstract][Full Text] [Related]
7. Toxicity and biodistribution assessment of curcumin-coated iron oxide nanoparticles: Multidose administration. Aboushoushah S; Alshammari W; Darwesh R; Elbaily N Life Sci; 2021 Jul; 277():119625. PubMed ID: 34015288 [TBL] [Abstract][Full Text] [Related]
8. Magnetic nanoparticles-loaded liposomes as a novel treatment agent for iron deficiency anemia: In vivo study. Fathy MM; Fahmy HM; Balah AMM; Mohamed FF; Elshemey WM Life Sci; 2019 Oct; 234():116787. PubMed ID: 31445028 [TBL] [Abstract][Full Text] [Related]
9. Glucose-coated superparamagnetic iron oxide nanoparticles prepared by metal vapour synthesis are electively internalized in a pancreatic adenocarcinoma cell line expressing GLUT1 transporter. Barbaro D; Di Bari L; Gandin V; Evangelisti C; Vitulli G; Schiavi E; Marzano C; Ferretti AM; Salvadori P PLoS One; 2015; 10(4):e0123159. PubMed ID: 25874906 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of iron oxide nanoparticle upon modulation of nanoparticle-bacteria interface. Arakha M; Pal S; Samantarrai D; Panigrahi TK; Mallick BC; Pramanik K; Mallick B; Jha S Sci Rep; 2015 Oct; 5():14813. PubMed ID: 26437582 [TBL] [Abstract][Full Text] [Related]
12. Biodistribution of antibody-targeted and non-targeted iron oxide nanoparticles in a breast cancer mouse model. Tate JA; Kett W; NDong C; Griswold KE; Hoopes PJ Proc SPIE Int Soc Opt Eng; 2013 Feb; 8584():85840G. PubMed ID: 25301995 [TBL] [Abstract][Full Text] [Related]
13. In vivo Biodistribution and Clearance of Magnetic Iron Oxide Nanoparticles for Medical Applications. Nowak-Jary J; Machnicka B Int J Nanomedicine; 2023; 18():4067-4100. PubMed ID: 37525695 [TBL] [Abstract][Full Text] [Related]
14. Tumor cell targeting by iron oxide nanoparticles is dominated by different factors in vitro versus in vivo. NDong C; Tate JA; Kett WC; Batra J; Demidenko E; Lewis LD; Hoopes PJ; Gerngross TU; Griswold KE PLoS One; 2015; 10(2):e0115636. PubMed ID: 25695795 [TBL] [Abstract][Full Text] [Related]
15. Alternating magnetic field-induced hyperthermia increases iron oxide nanoparticle cell association/uptake and flux in blood-brain barrier models. Dan M; Bae Y; Pittman TA; Yokel RA Pharm Res; 2015 May; 32(5):1615-25. PubMed ID: 25377069 [TBL] [Abstract][Full Text] [Related]
16. Stabilizing Alginate Confinement and Polymer Coating of CO-Releasing Molecules Supported on Iron Oxide Nanoparticles To Trigger the CO Release by Magnetic Heating. Meyer H; Winkler F; Kunz P; Schmidt AM; Hamacher A; Kassack MU; Janiak C Inorg Chem; 2015 Dec; 54(23):11236-46. PubMed ID: 26595858 [TBL] [Abstract][Full Text] [Related]
17. A 'degradable' poly(vinyl alcohol) iron oxide nanoparticle hydrogel. Bannerman AD; Li X; Wan W Acta Biomater; 2017 Aug; 58():376-385. PubMed ID: 28499634 [TBL] [Abstract][Full Text] [Related]
18. Iron oxide nanoparticle hyperthermia and chemotherapy cancer treatment. Petryk A; Giustini A; Ryan P; Strawbridge R; Hoopes P Proc SPIE Int Soc Opt Eng; 2009 Feb; 7181():71810N. PubMed ID: 25346581 [TBL] [Abstract][Full Text] [Related]
19. Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer. Miller-Kleinhenz J; Guo X; Qian W; Zhou H; Bozeman EN; Zhu L; Ji X; Wang YA; Styblo T; O'Regan R; Mao H; Yang L Biomaterials; 2018 Jan; 152():47-62. PubMed ID: 29107218 [TBL] [Abstract][Full Text] [Related]
20. Comparison study of ferrofluid and powder iron oxide nanoparticle permeability across the blood-brain barrier. Hoff D; Sheikh L; Bhattacharya S; Nayar S; Webster TJ Int J Nanomedicine; 2013; 8():703-10. PubMed ID: 23426527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]